Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice
about
Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domainThe latent transforming growth factor beta binding protein (LTBP) familyAtherosclerosisLipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbitsPlatelet-derived growth factor modulates rat vascular smooth muscle cell responses on laminin-5 via mitogen-activated protein kinase-sensitive pathwaysMapping of a minimal apolipoprotein(a) interaction motif conserved in fibrin(ogen) beta - and gamma -chainsFunctional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4).Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiographyEffect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus.Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cellsHypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic miceEffects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse.A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians.Immunohistochemical localization of defensin in human coronary vessels.Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation.Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity.Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study.Plasminogen activation: a mediator of vascular smooth muscle cell apoptosis in atherosclerotic plaquesLow density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia.Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice.Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.Convergent evolution of apolipoprotein(a) in primates and hedgehog.Inhibition of neointima formation through DNA vaccination for apolipoprotein(a): a new therapeutic strategy for lipoprotein(a)Genetic variation and atherosclerosis.Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus.The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptorGenomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.Baseline LDL-C and Lp(a) elevations portend a high risk of coronary revascularization in patients after stent placement.CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaquesThe recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.Sex hormones and lipoprotein(a) concentration.Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.
P2860
Q24291770-1D9C899B-96FE-46D4-A19C-59B5474D5BE2Q24532213-A0F7A447-C350-4EC9-8DBB-6A98F9022472Q24644573-634B8DA4-0C45-4924-83F3-2944EAFE0921Q24669902-EC3CE94D-D8D5-4FB4-BF5A-987B3DB7EFFEQ24798392-5F198366-A3C2-418A-A60A-83E168E77113Q28138192-D679EC4B-586C-4A25-9E4A-7BFCA8C0EA40Q31153622-B1A938E5-E925-486C-AFC7-A530A02107B9Q33909025-976722B6-CF77-459F-9AD9-2FD88CC14A40Q33939240-B3A5F822-799B-4752-8083-69ED5C9ACB50Q34797618-4BC62C03-1864-4EFA-9C2D-C783F0AE743BQ34897464-2B998F0F-BC97-498D-ADB0-3F10783E77A2Q35161070-EEB6996B-899B-40B6-B8D1-0E3138118981Q35465343-8E4CBD34-D13B-4D47-9186-4ACE1031D36CQ35659454-3217AD99-64BF-4559-B920-242590EF1F9EQ35741094-DA534F30-0182-43D2-9935-8605431CF566Q35750052-D192A3BC-CB8E-4C28-AD62-46D6182A680BQ35763559-C7C87E3D-90E0-4BEF-9AE6-36A541789200Q35796463-1AC6D257-A1BB-4DD1-8200-5AA9136D8183Q35798565-EB9F40D4-1AD7-41E8-8385-479508E5A185Q35799761-11F3F9CD-804A-4F1B-BDE8-F7F4C6D88BEFQ36185923-F8C9AC7E-928D-46E8-8D66-C9A6BAF332F8Q36462724-226B152F-EEF0-4E22-A5F1-7B08D7CB5D1AQ36476141-773113C3-A0FF-41EC-A59E-ECEB513564D3Q36502796-766ECB18-53D1-4814-88B0-4E177B6AE6ABQ36527433-21D6783B-15AA-44E8-A1D8-98D99102B059Q36586261-5FC86B5D-5B02-448A-A584-785AA2E8A240Q36633470-290730E7-3FD7-4CD1-9B1D-D0FA97420EA3Q36736883-3B369D2D-F59B-444A-9216-C41F166A2D72Q37172163-1E5F1724-7CBE-488D-93D8-531F470D4530Q37370315-172E2EC8-9F7E-4436-BB04-84F8C2E32805Q37372596-E5E51464-F97E-4625-83AF-A227C8918CC8Q37374146-FD63F4D8-C570-487F-BC64-69D171859990Q37374163-6FDF908E-1670-40A7-980E-2622C7B7A563Q37379082-593195BE-7133-40FC-8472-DD7EAE5173D5Q37400701-D706499D-B5E3-4FDC-A6BC-3DAD0EA48E96Q37418743-964EA68A-7CC5-4C1A-86A1-5AB0D797E97CQ37560277-25695A26-E60B-4483-B788-CBB31C94D8C2Q37561638-443A14BE-81A7-4F2D-BC9D-FC5C74926C17Q37825893-428DC3B5-7837-452B-AFE4-877B51E7F4C1Q37882523-5A2F7F28-F100-41EC-95B5-3B6D24D29E54
P2860
Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@ast
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@en
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@en-gb
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@nl
type
label
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@ast
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@en
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@en-gb
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@nl
prefLabel
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@ast
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@en
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@en-gb
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@nl
P2093
P3181
P356
P1433
P1476
Activation of transforming gro ...... nsgenic apolipoprotein(a) mice
@en
P2093
P2888
P3181
P356
10.1038/370460A0
P407
P577
1994-08-11T00:00:00Z
P6179
1040865675